dispersol technologies llc

DisperSol develops drug delivery platforms with compositions that could not be processed by other methods utilizing its patented technology

  • Stage $500K in TTM Revenue
  • Industry Healthcare Services
  • Location Georgetown, TX, USA
  • Currency USD
  • Founded August 2007
  • Employees 11
  • Website dispersoltech.com

Company Summary

DisperSol is a high growth company reformulating and manufacturing challenging existing drugs. Currently working with 3 companies delivering drugs for pre and clinical trials, planning to commercially manufacture these in its GMP facility. DisperSol is in advanced development of a tamper resistant platform for the manufacture of opioid drugs. Company has 3 issued patents and 3 patent applications. Currently expanding 3X capacity by Q4 2014

Team

  • Chris Brough, MSc, MBA
    VP, Technology

    Former VP Engineering at IntegriCo Composites. Inventor of underlying technology – 15 years experience in polymer manufacturing

  • Justin Keen, BSc ChE
    VP, Operations

    Former Director of Manufacturing at PharmaForm. Over 10 years experience in pharma processing and commercial manufacturing.

  • Gershon Yaniv, PhD, MBA
    CEO

    Former CEO of IntegriCo Composites, experienced entrepreneur with 25 years leading high tech companies. Former Professor mechanics of materials at Northwestern.

  • Dave Miller, PhD
    VP, R&D

    Dave is the former principal scientist in charge of reformulations and manufacturing for Hoffman, la Roche.

  • Gershon Yaniv

Previous Investors

  • Acadia Woods Partners, NYC
    Unconfirmed
    Chart Venture Partners, NYC
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free